Form 4: Zimmer Biomet Director Trades Phantom Stock Units

Maria Teresa Hilado, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.

Summary

• Maria Teresa Hilado, a Director of Zimmer Biomet Holdings, Inc., has reported transactions related to phantom stock units.
• These units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The reported transaction involves 389.498 phantom stock units.
• The conversion or exercise price is 1-for-1, with the underlying security being Common Stock.
• These units are to be settled in cash over ten annual installments starting within sixty days after the reporting person ceases to be a Director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard disclosure of executive compensation and does not indicate new buying or selling activity that would typically influence share price.

Future Outlook

The phantom stock units will be settled in cash in ten annual installments commencing within sixty days after the cessation of the reporting person's service as a Director.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing details the accrual and future settlement of phantom stock units, a common form of executive compensation.

Stakeholder Impact

• Shareholders: Increased transparency into director compensation and potential future cash outflows from the company for unit settlements.

Next Steps

• Settlement of phantom stock units in cash over ten annual installments after cessation of directorship.

Key Dates

Keywords

Zimmer Biomet Holdings, ZBH, Form 4, SEC Filing, Director, Phantom Stock Units, Deferred Compensation Plan, Insider Trading